Cohen M - Search Results

1

[Longitudinal study of health related quality of life in multiple sclerosis: correlation with MRI parameters].

Cohen M, Lebrun C, Aufauvre D, Chanalet S, Filleau-Bertogliatti C, Camu W, Thomas P, Malandain G, Clavelou P. Cohen M, et al. Rev Neurol (Paris). 2010 Nov;166(11):894-900. doi: 10.1016/j.neurol.2010.06.002. Epub 2010 Aug 21. Rev Neurol (Paris). 2010. PMID: 20728910 French.

2

[Depression in multiple sclerosis].

Lebrun C, Cohen M. Lebrun C, et al. Among authors: cohen m. Rev Neurol (Paris). 2009 Mar;165 Suppl 4:S156-62. doi: 10.1016/S0035-3787(09)72128-9. Rev Neurol (Paris). 2009. PMID: 19361681 Review. French.

3

[Natalizumab (Tysabri) prescription practices of neurologists in southern France].

Rocher F, Cohen M, Lebrun C. Rocher F, et al. Among authors: cohen m. Rev Neurol (Paris). 2010 Apr;166(4):412-8. doi: 10.1016/j.neurol.2009.09.008. Epub 2009 Oct 28. Rev Neurol (Paris). 2010. PMID: 19846185 French.

4

Giant urticaria and persistent neutralizing antibodies after the first natalizumab infusion.

Cohen M, Rocher F, Vivinus S, Thomas P, Lebrun C. Cohen M, et al. Neurology. 2010 Apr 27;74(17):1394-5. doi: 10.1212/WNL.0b013e3181dad567. Neurology. 2010. PMID: 20421585 No abstract available.

5

[Bilateral optic neuropathy with loss of vision after an influenza vaccination in a patient suffering from mixed connective tissue disease].

Laffon-Pioger M, Rocher F, Cohen M, Chanalet S, Thomas P, Lebrun C. Laffon-Pioger M, et al. Among authors: cohen m. Rev Neurol (Paris). 2010 Dec;166(12):1024-7. doi: 10.1016/j.neurol.2010.07.037. Epub 2010 Nov 10. Rev Neurol (Paris). 2010. PMID: 21067788 French.

6

Carnitine serum levels and levocarnitine administration in multiple sclerosis patients treated with natalizumab.

Laffon-Pioger M, Rocher F, Caruba C, Cohen M, Thomas P, Lebrun C. Laffon-Pioger M, et al. Among authors: cohen m. Eur J Neurol. 2011 Jun;18(6):e63-4. doi: 10.1111/j.1468-1331.2010.03332.x. Epub 2011 Jan 11. Eur J Neurol. 2011. PMID: 21219544 Clinical Trial. No abstract available.

7

[Bevacizumab for the treatment of cerebral radionecrosis].

Gronier S, Bourg V, Frenay M, Cohen M, Mondot L, Thomas P, Lebrun C. Gronier S, et al. Among authors: cohen m. Rev Neurol (Paris). 2011 Apr;167(4):331-6. doi: 10.1016/j.neurol.2010.10.012. Epub 2011 Mar 21. Rev Neurol (Paris). 2011. PMID: 21420137 French.

8

Cutaneous Side-effects of Immunomodulators in MS.

Lebrun C, Bertagna M, Cohen M. Lebrun C, et al. Among authors: cohen m. Int MS J. 2011 Sep;17(3):88-94. Int MS J. 2011. PMID: 21689492

9

[Neurological adverse events under anti-TNF alpha therapy].

Cohen M, Baldin B, Thomas P, Lebrun C. Cohen M, et al. Rev Neurol (Paris). 2012 Jan;168(1):33-9. doi: 10.1016/j.neurol.2011.06.005. Epub 2011 Nov 17. Rev Neurol (Paris). 2012. PMID: 22098827 French.

10

[Hematological side effects of natalizumab: Correlation with clinical outcome].

Bresch S, Cohen M, Rocher F, Laffon M, Thomas P, Lebrun C. Bresch S, et al. Among authors: cohen m. Rev Neurol (Paris). 2012 Feb;168(2):116-20. doi: 10.1016/j.neurol.2011.07.013. Epub 2011 Nov 17. Rev Neurol (Paris). 2012. PMID: 22100322 French.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

12,917 results

Search Page

Filters